Insulin agents expand therapeutic options, increase medication adherence, reduce injection burden, and lead to improved physiological function. However, more products mean more complications for patients with diabetes as well as pharmacists and other health professionals. In this session, two experts will illustrate how to individualize insulin therapy, avoid clinical inertia, and initiate or intensify insulin therapy for positive outcomes. Through a series of clinical case vignettes of patients with diabetes, you’ll discuss treatment options, including insulin pharmacokinetic and pharmacodynamic characteristics, monitoring, titrating, and care coordinating.
At the completion of this application-based activity, participants will be able to:
At the completion of this application-based activity, participants will be able to: